The trademark UNIQUE was filed by Genzyme Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on May 9, 2021, and received one opposition filed on August 5, 2021 by TERAPIA S.A. on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 5, 2021
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on February 1, 2022. Change of name and address of the trademark registration was recorded on August 16, 2022.
The Appeal with reference B R0340/2023-5 was Proceedings terminated according to Article 109(3) EUTMR with decision issued on February 11, 2024 by the EUIPO. The Opposition with reference B 003152209 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on January 29, 2023 by the EUIPO.